newsfilter
← Latest News
GlobeNewswire·

Radiopharm Theranostics Reports Business Update

Reported positive results from the Phase 2b clinical trial of imaging agent RAD 101, showing 93% of evaluable patients treated with RAD 101 achieved the primary endpoint Plans to initiate Phase 3 registrational trial